L01 Antineoplastic agents
ATC group of level 2 – therapeutic subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 1,025 medicines in this group and its subgroups.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
-
L01 Antineoplastic agents 1,025 medicines
- L01A Alkylating agents 123 medicines
- L01B Antimetabolites 182 medicines
- L01C Plant alkaloids and other natural products, antineoplastic drugs 97 medicines
- L01D Cytotoxic antibiotics and related substances 42 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01X Other antineoplastic agents 225 medicines
-
L01 Antineoplastic agents 1,025 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Zanosar 1 g powder for concentrate for solution for infusion (L01AD04 streptozocin) | Prescription only (POM) |
| Zavedos 1 mg / ml solution for injection SPC (L01DB06 idarubicin) | – |
| Zavedos 5 mg powder for solution for injection (L01DB06 idarubicin) | Prescription only (POM) |
| Zavedos capsules 10 mg SPC (L01DB06 idarubicin) | Prescription only (POM) |
| Zavedos capsules 5 mg SPC (L01DB06 idarubicin) | Prescription only (POM) |
| Zejula 100 mg film-coated tablets (L01XK02 niraparib) | Prescription only (POM) |
| Zejula 100 mg hard capsule SPC no longer supplied (L01XK02 niraparib) | – |
| Zelboraf 240 mg film-coated tablets SPC (L01EC01 vemurafenib) | Prescription only (POM) |
| Zepzelca 4 mg powder for concentrate for solution for infusion SPC (L01XX69 lurbinectedin) | – |
| Zercepac 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) | Prescription only (POM) |
| Zercepac 420 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) | Prescription only (POM) |
| Zercepac 60 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) | Prescription only (POM) |
| Zirabev 100 mg / 4 ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) | – |
| Zlatal 10 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 12.5 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 15 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 17.5 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 20 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 22.5 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 25 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zlatal 7.5 mg solution for injection in Pre-filled syringe SPC (L01BA01 methotrexate) | Prescription only (POM) |
| Zydelig 100 mg film-coated tablets SPC (L01EM01 idelalisib) | Prescription only (POM) |
| Zydelig 150 mg film-coated tablets SPC (L01EM01 idelalisib) | Prescription only (POM) |
| Zykadia 150 mg film-coated tablets SPC (L01ED02 ceritinib) | Prescription only (POM) |
| Zykadia 150 mg hard capsules SPC no longer supplied (L01ED02 ceritinib) | – |
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
